Thoratec Receives FDA Approval of Continued Access Protocol for Bridge Arm of Its HeartMate(R) II Pivotal Trial (PR Newswire via Yahoo! Finance)
Thoratec Corporation , a world leader in products to treat cardiovascular disease, today said that the FDA has approved an IDE supplement that allows enrollment of up to an additional 90 patients in the Bridge-to-Transplantation arm of the company's HeartMate II Phase II trial under a Continued Access Protocol .

AZILECT(R) FDA Approval Brings New Hope to People Living With Parkinson's Disease (PR Newswire via Yahoo! Finance)
The U.S. Food and Drug Administration has approved AZILECT , the first once-daily oral treatment for Parkinson's disease .

FDA Advisory Committee Recommends Approval Of Exelon(R) (rivastigmine Tartrate) In The Treatment Of Dementia Associated (Medical News Today)
Novartis announced thatExelon (rivastigmine tartrate) received a favorable opinion from thePeripheral and Central Nervous System Drugs Advisory Committee of the U.S.Food and Drug Administration (FDA) for the treatment of mild to moderatedementia associated with Parkinson's disease. [click link for full article]